Attached files

file filename
10-Q/A - 10-Q/A - BioRestorative Therapies, Inc.v232728_10qa.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R3.htm
EXCEL - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R11.htm
v2.3.0.11
Condensed Consolidated Statements of Cash Flows (USD $)
6 Months Ended 30 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Cash Flows From Operating Activities      
Net loss $ (2,317,937) $ (662,658) $ (5,778,862)
Adjustments to reconcile net loss to net cash used in operating activities:      
Amortization of debt discount 178,848 140,621 389,575
Depreciation and amortization 52,403 14,145 107,173
Stock-based compensation 344,168 107,450 2,169,493
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets (58,170) 3,124 (58,170)
Security deposit (4,415)   (4,415)
Accounts payable 148,292 19,831 248,479
Accrued expenses and other current liabilities 236,057 12,746 573,675
Total Adjustments 897,183 297,917 3,425,810
Net Cash Used in Operating Activities (1,420,754) (364,741) (2,353,052)
Cash Flows From Investing Activities      
Purchases of property and equipment (17,772) (39,577) (163,243)
Acquistion of intangible assets   (2,200) (3,676)
Net Cash Used in Investing Activities (17,772) (41,777) (166,919)
Cash Flows From Financing Activities      
Proceeds from notes payable 1,637,500 37,900 2,248,639
Repayments of notes payable (209,863) (130,975) (386,658)
Sale of common stock for cash   501,300 691,300
Proceeds from exercise of warrrants     1,875
Repurchase of common stock     (28,000)
Net Cash Provided by Financing Activities 1,427,637 408,225 2,527,156
Net (Decrease) Increase In Cash (10,889) 1,707 7,185
Cash - Beginning 18,074 42  
Cash - Ending 7,185 1,749 7,185
Cash paid during the period for:      
Interest 36,274 7,350 53,121
Non-cash investing and financing activites:      
Shares issuable as debt discount in connection with note payable 6,971    
Purchase of property and equipment for note payable     291,055
Purchase of property and equipment for account payable     60,000
Accrued payable for treasury shares repurchased     7,000
Shares reissued to former President 12,577   12,577
Shares (returned) issued as collateral in connection with note payable   (530,000)  
Shares issued as debt discount in connection with notes payable
     
Non-cash investing and financing activites:      
Shares issued 235,490   458,722
Shares issued in connection with reverse recapitalization
     
Non-cash investing and financing activites:      
Shares issued     362,000
Shares issued pursuant to reverse recapitalization and subsequently cancelled
     
Non-cash investing and financing activites:      
Shares issued     $ 146,195